Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$373M |
| 2 |
Costco
COST
|
+$283M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$270M |
| 4 |
Pfizer
PFE
|
+$240M |
| 5 |
Microsoft
MSFT
|
+$225M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$274M |
| 2 |
EMC
EMC CORPORATION
EMC
|
+$228M |
| 3 |
GAS
AGL Resources Inc
GAS
|
+$216M |
| 4 |
TE
TECO ENERGY INC
TE
|
+$136M |
| 5 |
Charter Communications
CHTR
|
+$133M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.75% |
| 2 | Healthcare | 13.12% |
| 3 | Financials | 12.46% |
| 4 | Consumer Staples | 9.7% |
| 5 | Industrials | 9.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ADAP
2101
DELISTED
Adaptimmune Therapeutics
ADAP
| $2.32M | ﹤0.01% |
328,700
+139,500
| +74% | +$1.06M |
|
2102
Lifeway Foods
LWAY
$395M
| $2.32M | ﹤0.01% |
136,700
-3,300
| -2% | -$40.1K |
|
|
FCB
2103
DELISTED
FCB Financial Holdings, Inc.
FCB
| $2.31M | ﹤0.01% |
+60,200
| New | +$2.22M |
|
2104
Rigel Pharmaceuticals
RIGL
$795M
| $2.31M | ﹤0.01% |
62,980
-16,280
| -21% | -$467K |
|
|
AVEO
2105
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
| $2.31M | ﹤0.01% |
259,540
+19,000
| +8% | +$179K |
|
2106
National Bankshares
NKSH
$270M
| $2.31M | ﹤0.01% |
62,700
-500
| -0.8% | -$17.5K |
|
2107
World Acceptance Corp
WRLD
$908M
| $2.31M | ﹤0.01% |
47,000
+34,500
| +276% | +$1.65M |
|
2108
Idacorp
IDA
$8.25B
| $2.29M | ﹤0.01% |
29,300
-49,400
| -63% | -$3.9M |
|
|
RTK
2109
DELISTED
Rentech, Inc.
RTK
| $2.29M | ﹤0.01% |
784,974
-6,536
| -0.8% | -$19.8K |
|
2110
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.9B
| $2.28M | ﹤0.01% |
42,900
-65,400
| -60% | -$3.56M |
|
|
ESND
2111
DELISTED
Essendant Inc.
ESND
| $2.28M | ﹤0.01% |
+110,922
| New | +$2.45M |
|
|
NSTG
2112
DELISTED
NanoString Technologies, Inc.
NSTG
| $2.27M | ﹤0.01% |
+113,700
| New | +$1.8M |
|
2113
Dover
DOV
$27.9B
| $2.27M | ﹤0.01% |
+38,130
| New | +$2.21M |
|
|
AMNB
2114
DELISTED
American National Bankshares Inc
AMNB
| $2.27M | ﹤0.01% |
81,110
+6,010
| +8% | +$160K |
|
2115
M/I Homes
MHO
$3.85B
| $2.26M | ﹤0.01% |
96,000
+76,100
| +382% | +$1.68M |
|
|
STON
2116
DELISTED
StoneMor Inc.
STON
| $2.26M | ﹤0.01% |
90,188
-105,612
| -54% | -$2.66M |
|
2117
Howard Hughes
HHH
$3.98B
| $2.26M | ﹤0.01% |
20,665
-22,029
| -52% | -$2.44M |
|
2118
Plains GP Holdings
PAGP
$5.11B
| $2.25M | ﹤0.01% |
65,340
-342,170
| -84% | -$10.3M |
|
2119
Acme United Corp
ACU
$232M
| $2.25M | ﹤0.01% |
107,600
+5,900
| +6% | +$122K |
|
|
TESO
2120
DELISTED
Tesco Corp
TESO
| $2.24M | ﹤0.01% |
274,600
-91,100
| -25% | -$644K |
|
2121
Agilysys
AGYS
$3.22B
| $2.24M | ﹤0.01% |
201,100
+16,100
| +9% | +$175K |
|
2122
Diana Shipping
DSX
$309M
| $2.23M | ﹤0.01% |
1,220,067
+238,721
| +24% | +$438K |
|
|
SFE
2123
DELISTED
Safeguard Scientifics, Inc.
SFE
| $2.23M | ﹤0.01% |
172,300
+36,100
| +27% | +$479K |
|
2124
Camtek
CAMT
$7.72B
| $2.22M | ﹤0.01% |
739,000
+51,400
| +7% | +$132K |
|
|
AVXS
2125
DELISTED
AveXis, Inc. Common Stock
AVXS
| $2.22M | ﹤0.01% |
53,900
+48,069
| +824% | +$1.83M |
|
Similar funds
Jim Simons's Q3 2016 Portfolio in Review
As of Q3 2016, Jim Simons held 3,713 positions worth $56.6B, up 7.7% from $52.5B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Jim Simons deployed $1.92B of net new capital in Q3 2016, opening 414 new positions and adding to 1,834 existing holdings. Its largest new stake was FedEx: 811,400 shares worth $142M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was CVS Health, an estimated $274M trimmed.
- Jim Simons's largest Q3 2016 buy was FedEx: 811,400 shares worth $142M.
- Jim Simons added most to Alphabet (Google) Class A in Q3 2016, an estimated $373M increase.
- Jim Simons's biggest Q3 2016 reduction was CVS Health, cutting an estimated $274M.
- Jim Simons fully exited EMC CORPORATION in Q3 2016, selling an estimated $228M.
- Jim Simons's ten largest holdings make up 7.9% of its $56.6B portfolio in Q3 2016.
- Jim Simons opened 414 new positions and closed 416 in Q3 2016.
- Jim Simons's portfolio value rose 7.7% quarter-over-quarter to $56.6B.
Based on Renaissance Technologies's 13F filing for Q3 2016, filed 14 Nov 2016.